85
Views
4
CrossRef citations to date
0
Altmetric
Review

Recombinant DNA technology for producing new rinderpest virus vaccines

Pages 113-120 | Published online: 09 Jan 2014

References Papers of special note have been highlighted as: • of interest •• of considerable interest

  • Barrett T, Rossiter PB. Rinderpest: the disease and its impact on human and animals. Adv. Virus Res.53, 89–110 (1999).
  • Mack R. The great African cattle plague epidemic of the 1890’s. Trop. Anim. Health Prod.2, 210–219 (1970).
  • Rweyemamu MM, Cheneau Y. Strategy for the global rinderpest eradication program. Vet. Microbiol.44(2–4), 369–376 (1995).
  • Rweyeymamu MM. Rinderpest. EMPRES: Transboundary Animal Dis. Bull.12, 2–5 (1999).
  • Spinage CA. Cattle Plague: A History. Kluwer Academic/Plenum Publishers, NY, USA (2003).
  • Brotherston JG. Rinderpest: some notes on control by modified virus vaccines. 2. The modified virus variants of rinderpest. II. Lapinized virus. Vet. Rev. Annotations3, 45–56 (1957).
  • Edwards JT. The uses and limitations of the caprinized virus in the control of rinderpest (cattle plague) among British and Near-Eastern cattle. Br. Vet. J.105, 209–253 (1949).
  • Nakamura JJ, Miyamoto T. Avianization of lapinized rinderpest virus. Am. J. Vet. Res.14(51), 307–317 (1953).
  • Daubney R. Recent developments in rinderpest control. Bull. Off. Int. Epizoot.26, 36–45 (1947).
  • Plowright W, Ferris RD. Studies with rinderpest virus in tissue culture. The use of attenuated culture virus as a vaccine for cattle. Res. Vet. Sci.3, 172–182 (1962).
  • Plowright W, Taylor WP. Long-term studies of the immunity in East African cattle following inoculation with rinderpest culture vaccine. Res. Vet. Sci.8(1), 118–128 (1967).
  • Johnson RH. Rinderpest in tissue culture. III. Use of the attenuated strain as a vaccine for cattle. Br. Vet. J.118, 141–150 (1962).
  • Mariner JC, House JA, Sollod AE et al. Comparison of the effect of various chemical stabilizers and lyophilization cycles on the thermostability of a Vero cell-adapted rinderpest vaccine. Vet. Microbiol.21, 195–209 (1990).
  • Yamanouchi K, Barrett T, Kai C. New approaches to the development of virus vaccines for veterinary use. Rev. Sci. Tech.17(3), 641–653 (1998).
  • Mackett M, Smith GL, Moss B. Vaccinia virus: a selectable eukaryotic cloning and expression vector. Proc. Natl Acad. Sci. USA79(23), 7415–7419 (1982).
  • Pastoret PP, Brochier B. The development and use of a vaccinia–rabies recombinant oral vaccine for the control of wildlife rabies; a link between Jenner and Pasteur. Epidemiol. Infect.116(3), 235–240 (1996).
  • Yilma T, Hsu D, Jones L et al. Protection of cattle against rinderpest with vaccinia virus recombinants expressing the HA or F gene. Science242, 1058–1061 (1988).
  • Barrett T, Belsham GJ, Subbarao SM, Evans SA. Immunization with a vaccinia recombinant expressing the F protein protects rabbits from challenge with a lethal dose of rinderpest virus. Virology170(1), 11–18 (1989).
  • Office International des Epizooties. Report of the expert consultation on requirements for vaccinia–rinderpest recombinant (VRR) vaccines. Paris, France (1989).
  • Giavedoni L, Jones L, Mebus C, Yilma T. A vaccinia virus double recombinant expressing the F and H genes of rinderpest virus protects cattle against rinderpest and causes no pock lesions. Proc. Natl Acad. Sci. USA88, 8011–8015 (1991).
  • Yamanouchi K, Inui K, Sugimoto M et al. Immunization of cattle with a recombinant vaccinia vector expressing the hemagglutinin gene of rinderpest virus. Vet. Rec.132, 152–156 (1993).
  • Kitching RP, Hammond JM, Taylor WP. A single vaccine for the control of capripox infection in sheep and goats. Res. Vet. Sci.42(1), 53–60 (1987).
  • Romero CH, Barrett T, Chamberlain RW et al. Recombinant capripoxvirus expressing the hemagglutinin protein gene of rinderpest virus: protection of cattle against rinderpest and lumpy skin disease viruses. Virology204, 425–429 (1994).
  • Romero CH, Barrett T, Kitching RP, Carn VM, Black DN. Protection of cattle against rinderpest and lumpy skin disease with a recombinant capripoxvirus expressing the fusion protein gene of rinderpest virus. Vet. Rec.135, 152–154 (1994).
  • Romero CH, Barrett T, Evans SA et al. Single capripoxvirus recombinant vaccine for the protection of cattle against rinderpest and lumpy skin disease. Vaccine11(7), 737–742 (1993).
  • Ngichabe CK, Wamwayi HM, Barrett T et al. Trial of a capripoxvirus–rinderpest recombinant vaccine in African cattle. Epidemiol. Infect.118(1), 63–70 (1997).
  • Berhe G, Minet C, Le Goff C et al. Development of a dual recombinant vaccine to protect small ruminants against peste des petits ruminants virus and capripoxvirus infections. J. Virol.77(2), 1571–1577 (2003).
  • Conzelmann K-K, Schnell M. Rescue of synthetic genomic RNA analogs of rabies virus by plasmid-encoded proteins. J. Virol.68, 713–719 (1994).
  • Baron MD, Barrett T. Rescue of recombinant rinderpest virus from cloned cDNA. J. Virol.71, 1265–1271 (1997).
  • Whelan SPJ, Barr JN, Wertz GW. Transcription and replication of nonsegmented negative-strand RNA viruses. Curr. Top. Microbiol. Immunol.283, 61–119 (2004).
  • Walsh EP, Baron MD, Anderson J, Barrett T. Development of a genetically marked recombinant rinderpest vaccine expressing green fluorescent protein. J. Gen. Virol.81(3), 709–718 (2000).
  • Walsh EP, Baron MD, Rennie LF et al. Recombinant rinderpest vaccines expressing membrane-anchored proteins as genetic markers: evidence of exclusion of marker protein from the virus envelope. J. Virol.74(21), 10165–10175 (2000).
  • van Oirschot JT, Terpstra C, Moormann RJ, Berns AJ, Gielkens AL. Safety of an Aujeszky’s disease vaccine based on deletion mutant strain 783 which does not express thymidine kinase and glycoprotein I. Vet. Rec.127(18), 443–446 (1990).
  • Baron MD, Barrett T. Rinderpest viruses lacking the C and V proteins show specific defects in growth and transcription of viral RNAs. J. Virol.74(6), 2603–2611 (2000).
  • Das SC, Baron MD, Barrett T. Recovery and characterization of a chimeric rinderpest virus with the glycoproteins of peste des petits ruminants virus: homologous F and H proteins are required for virus viability. J. Virol.74(19), 9039–9047 (2000).
  • Anderson J, Barrett T, Scott G R. Manual on the diagnosis of rinderpest. FAO Rome, Italy (1996).
  • Libeau G, Prehaud C, Lancelot R et al. Development of a competitive ELISA for detecting antibodies to the peste des petits ruminants virus using a recombinant nucleoprotein. Res. Vet. Sci.58(1), 50–55 (1995).
  • Mebatsion T, Koolen MJ, de Vaan LT et al. Newcastle disease virus (NDV) marker vaccine: an immunodominant epitope on the nucleoprotein gene of NDV can be deleted or replaced by a foreign epitope. J. Virol.76(20), 10138–10146 (2002).
  • Bassiri M, Ahmad S, Giavedoni L et al. Immunological responses of mice and cattle to baculovirus-expressed F and H proteins of rinderpest virus – lack of protection in the presence of neutralizing antibody. J. Virol.67, 1255–1261 (1993).
  • Kamata H, Ohishi K, Hulskotte E et al. Rinderpest virus (RPV) ISCOM vaccine induces protection in cattle against virulent RPV challenge. Vaccine19(25–26), 3355–3359 (2001).
  • Jones L, Giavedoni L, Saliki JT et al. Protection of goats against peste des petits ruminants with a vaccinia virus double recombinant expressing the F gene and H gene of rinderpest virus. Vaccine11, 961–964 (1993).
  • Romero CH, Barrett T, Kitching RP, Bostock C, Black DN. Protection of goats against peste des petits ruminants with recombinant capripoxviruses expressing the fusion and hemagglutinin protein genes of rinderpest virus. Vaccine13(1), 36–40 (1995).
  • De Vries P, Vanbinnendijk RS, Vandermarel P et al. Measles virus fusion protein presented in an immune-stimulating complex (ISCOM) induces hemolysis-inhibiting and fusion-inhibiting antibodies, virus-specific T-cells and protection in mice. J. Gen. Virol.69, 549–559 (1988).
  • Ennis FA, Cruz J, Jameson J et al. Augmentation of human influenza A virus-specific cytotoxic T-lymphocyte memory by influenza vaccine and adjuvanted carriers (ISCOMS). Virology259(2), 256–261 (1999).
  • Ohishi K, Kamata H, Yamanouchi K, Barrett T. Identification of T-helper cell epitopes in the hypervariable region of the nucleocapsid (N) protein of rinderpest virus (RPV) in cattle. Vaccine18(27), 3077–3081 (2000).
  • Rahman MM, Shaila MS, Gopinathan KP. Baculovirus display of fusion protein of peste des petits ruminants virus and hemagglutination protein of rinderpest virus and immunogenicity of the displayed proteins in mouse model. Virology317(1), 36–49 (2003).
  • Renukaradhya GJ, Mitra-Kaushik S, Sinnathamby G, Rajasekhar M, Shaila MS. Mapping of B-cell epitopes of hemagglutinin protein of rinderpest virus. Virology298, 214–223 (2002).
  • Sugiyama M, Ito N, Minamoto N, Tanaka S. Identification of immunodominant neutralizing epitopes on the hemagglutinin protein of rinderpest virus. J. Virol.76, 1691–1696 (2002).
  • Sinnathamby G, Seth S, Nayak R, Shaila MS. Cytoxic T-cell epitope in cattle from the attachment glycoproteins of rinderpest and peste des petits ruminants viruses. Viral Immunol.17, 401–410 (2004).
  • Inui K, Barrett T, Kitching RP, Yamanouchi K. Long term immunity in cattle vaccinated with a recombinant rinderpest vaccine. Vet. Rec.137, 669–670 (1995).
  • Ngichabe CK, Wamwayi HM, Ndungu1 EK et al. Long-term immunity in african cattle vaccinated with a recombinant capripox-rinderpest virus vaccine. Epidemiol. Infect.128, 343–349 (2002).
  • Verardi PH, Aziz FH, Ahmad S et al. Long-term sterilizing immunity to rinderpest in cattle vaccinated with a recombinant vaccinia virus expressing high levels of the fusion and haemagglutinin glycoproteins. J. Virol.76, 484–491 (2002).
  • Roeder PL, Taylor WP. Rinderpest. Vet. Clin. Food Animals18, 515–547 (2002).
  • Fenner F, Henderson DA, Arita I, Jezek Z, Ladnyi ID. Smallpox and its eradication. WHO, Geneva ISBN: 92 4 156110 6 (1988).
  • Barrett T, Forsyth M, Inui K et al. Rediscovery of the second African lineage of rinderpest virus: its epidemiological significance. Vet. Rec.142, 669–671 (1998).
  • Kock RA, Wambua J, Mwanzia J. Rinderpest epidemic in wild ruminants in Kenya 1993–1997. Vet. Rec.145, 275–283 (1999).
  • Perry BD, Randolph TF, McDermott JJ, Sones KR, Thornton PK. Investing in animal health research to alleviate poverty. ILRI (International Livestock Research Institute), Nairobi, Kenya 148 (2002).
  • Khandelwal A, Renukaradhya GJ, Rajasekhar M, Sita GL, Shaila MS. Systemic and oral immunogenicity of hemagglutinin protein of rinderpest virus expressed by transgenic peanut plants in a mouse model. Virology323, 284–291 (2004).
  • Prasad V, Satyavathi VV, Valli SKM et al. Expression of biologically active hemagglutinin-neuraminidase protein of peste des petits ruminants virus in transgenic pigeonpea (Cajanus cajan (L) Millsp.). Plant Sci.166, 199–205 (2004).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.